Progressive Pressure Support Reduction as Inspiratory Muscle Endurance Training in Mechanically Ventilated Patients

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Santiago de Compostela

About this trial

Mechanical ventilation causes rapid diaphragm muscle atrophy, detectable within 18 hours of ventilator support, which is a major contributor to weaning failure and prolonged ICU stay.

This randomized controlled trial tests whether a physiotherapist-guided inspiratory endurance training program - achieved by progressively reducing pressure support (PS) levels on the ventilator - can preserve or improve inspiratory muscle strength and diaphragm structure in critically ill adults on mechanical ventilation, compared to standard ICU care.

Participants will be randomly assigned to one of two groups. The intervention group will receive twice-daily training sessions (weekdays only) in which the physiotherapist gradually reduces PS by up to 50% of the baseline level, causing the patient to breathe with greater muscular effort - equivalent to progressive endurance exercise for the diaphragm. The control group will receive standard weaning care as directed by the attending intensivist.

The primary outcome is maximal inspiratory pressure (PImax) at day 7. Secondary outcomes include diaphragm thickening fraction measured by ultrasound, time to successful extubation, weaning success rate, and mortality.

All measurements are performed by the ICU physician (blinded to group allocation) using airway occlusion maneuvers recorded on the ventilator and diaphragm ultrasound, following a standardized protocol.

Eligibility criteria

Qualifiers

Age ≥ 18 years

Admitted to ICU with invasive mechanical ventilation for more than 48 hours at the time of randomization

Expected to remain intubated for at least 24 additional hours, at the discretion of the attending intensivist

Active pressure support ventilation (PSV) mode with PS level ≥ 5 cmH2O

Disqualifiers

Neurological condition affecting central respiratory control (high cervical spinal cord injury, ALS, myasthenia gravis, active Guillain-Barré syndrome)

Established tracheostomy at the time of inclusion

Restriction on head-of-bed elevation to ≥ 30 degrees

Decision to limit therapeutic effort (LET) or life expectancy < 48 hours

Trial design

Treatments tested in this trial

  • Progressive Pressure Support Reduction (IRT-PS)
  • Standard ICU Care

Treatment groups

60 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Santiago de Compostela

Lead sponsor

University of Vigo

Sponsor institution